Katrin Schindler
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer.
Journal: Journal of advanced research
Published: December 30, 2024
Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence.
Journal: Cell communication and signaling : CCS
Published: September 05, 2024
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 06, 2024
The lncRNAs PART1 and ADAMTS9-AS2 act in an antithetic manner on AR signaling and induction of cellular senescence in prostate cancer cells.
Journal: International journal of surgery (London, England)
Published: July 26, 2024
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.
Journal: Oncogene
Published: August 18, 2021
Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice.
Journal: Journal of the renin-angiotensin-aldosterone system : JRAAS
Published: May 19, 2020
Wild-type FLT3 and FLT3 ITD exhibit similar ligand-induced internalization characteristics.
Journal: Journal of cellular and molecular medicine
Published: September 30, 2019
Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 16, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026